Genomic Health, Inc. (GHDX) Misses Q4 EPS by 2c, Offers FY12 Sales Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Total revenues: 245.13M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Total revenues: 245.13M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q4 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $53.4 million versus the consensus estimate of $53.83 million.
Genomic Health, Inc. sees FY2012 revenue of $230-$240 million, versus the consensus of $236.28 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Genomic Health, Inc. sees FY2012 revenue of $230-$240 million, versus the consensus of $236.28 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
- Bristol Myers Squibb MS CAR T therapy data shows patients off DMTs
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
